Showing results (111-120 of 311) with videos related to

Sort By:
Pageof 32
Neurology|October 15, 2017
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 15, 2009
Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's diseaseVolker Welge, Oliver Fiege, Piotr Lewczuk, et al.
Gene|March 19, 2020
A novel pathogenic variant in MYO18B associating early-onset muscular hypotonia, and characteristic dysmorphic features, delineation of the phenotypic spectrum of MYO18B-related conditionsTheresa Brunet, Dominik S Westphal, Sandrina Weber, et al.
Neurobiology of Disease|November 17, 2019
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's diseaseFabian Maass, Bernhard Michalke, Desiree Willkommen, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive DeclineAnna Emdina, Peter Hermann, Daniela Varges, et al.
Analytical and Bioanalytical Chemistry|July 13, 2022
Studying the Parkinson's disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot studyBegoña Talavera Andújar, Dagny Aurich, Velma T E Aho, et al.
NPJ Parkinson'S Disease|March 20, 2021
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylaseAnouke van Rumund, Lukas Pavelka, Rianne A J Esselink, et al.
Biomarkers in Medicine|March 30, 2017
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's diseaseNaomi P Visanji, Brit Mollenhauer, Thomas G Beach, et al.
Dementia and Geriatric Cognitive Disorders|April 2, 2005
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Petra Steinacker, Brit Mollenhauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 8, 2017
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohortTanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, et al.
Pageof 32